Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.

Ítems similars

• Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
  per: Whelan, K, et al.
  Publicat: (2009)
• Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.
  per: Fletcher, H, et al.
  Publicat: (2008)
• Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
  per: Mcshane, H, et al.
  Publicat: (2005)
• Polyfunctional T cell responses are a hallmark of HIV-2 infection.
  per: Duvall, MG, et al.
  Publicat: (2008)
• Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
  per: Kathryn T. Whelan, et al.
  Publicat: (2011-01-01)